Control of bone remodelling

Constant remodelling of bones — up to 10% of the total mass every year — helps to maintain the optimal levels of calcium in the blood and also the structural function of the skeleton, but the identity of the molecules involved in controlling this process remains unclear. In April 18 Nature, Hiroshi Takayanagi and colleagues from University of Tokyo show that interferon-β (IFN-β) is pivotal in regulating bone homeostasis (Nature 2002, 416:744-749).Takayanagi et al. observed

By | April 22, 2002

Constant remodelling of bones — up to 10% of the total mass every year — helps to maintain the optimal levels of calcium in the blood and also the structural function of the skeleton, but the identity of the molecules involved in controlling this process remains unclear. In April 18 Nature, Hiroshi Takayanagi and colleagues from University of Tokyo show that interferon-β (IFN-β) is pivotal in regulating bone homeostasis (Nature 2002, 416:744-749).

Takayanagi et al. observed that mice deficient in IFN-β exhibit severe loss of bone mass accompanied by enhanced osteoclastogenesis. Using this model they found that receptor activator of NF-κB ligand (RANKL) induced IFN-β in osteoclast precursor cells, and that IFN-β inhibited the differentiation by interfering with the RANKL-induced expression of c-Fos — a transcription factor essential for the formation of osteoclasts.

"This IFN-β gene induction is distinct from that induced by virus infections, and is dependent on c-Fos itself" wrote the authors.

"These new observations suggest that the targeted use of IFN-β might be beneficial for treating diseases such as osteoporosis, rheumatoid arthritis and periodontal disease, in which bone resorption is inappropriately high," said Tamara Alliston and Rik Derynck of University of California at San Francisco in an accompanying News and Views article.

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech